Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: an analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)
Shin, J.; Muniz-Terrera, G.; Ritchie, C.; Manson, J.; Plachecki, S.; Kirschbaum, C.; Gregory, S.
Show abstract
INTRODUCTION: Postmenopausal estrogen decline may contribute to Alzheimer's disease (AD) risk, but longitudinal evidence linking circulating estrogens to cerebrospinal fluid (CSF) biomarkers is lacking. METHODS: We analyzed 866 female participants from the European Prevention of AD Longitudinal Cohort Study with baseline serum estradiol and estrone measured by liquid chromatography tandem mass spectrometry and repeated CSF measurements of amyloid-beta (A{beta})42, phosphorylated (p) Tau181, and total (t) Tau. RESULTS: Neither estradiol nor estrone was associated with longitudinal A{beta}42. Higher estradiol was associated with lower baseline tau and slower tau increases over time. Baseline estradiol-tau associations were stronger in apolipoprotein E (APOE) {epsilon}4 carriers, though APOE{epsilon}4 did not modify longitudinal associations. Amyloid positivity did not moderate hormone-tau associations but was associated with steeper tau increases over time. Estrone showed no significant associations. DISCUSSION: These findings suggest a more consistent relationship between estradiol and tau-related rather than amyloid-related pathology.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Peripheral inflammation is associated with structural brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer's disease 93%
- Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification 92%
- PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer's disease 92%
Similar papers in this journal
- CSF sphingomyelins in Alzheimer’s disease, neurodegeneration, and neuroinflammation 95%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 94%
- Inflammation in Alzheimer's disease: do sex and APOE matter? 94%
Similar papers in this journal
Similar papers in this journal
- D-Methionine Improves Spatial Navigation and Attenuates Oxidative Stress and Amyloid Pathology in a Sex-Specific Manner 94%
- Altered Hippocampal Glutamatergic Neurotransmission and Cognitive Impairment in APP Knock-In Mice 92%
- Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13 92%